menu search

Why shares of blueprint medicines are falling wednesday

Blueprint medicines announced increased revenue and decreased losses. The company's lead therapy, Ayvak...

August 2, 2023, 1:00 pm

3 consumer staples stocks to dump asap

Investing in companies that make products people buy day-in and day-out is a smart way to weather an economic storm, but there are some consumer stapl...

August 2, 2023, 9:47 am

Amerisourcebergen forecasts upbeat annual profit as weight-loss drugs lift results

Drug distributor AmerisourceBergen raised its full-year profit forecast on Wednesday, as soaring demand for weight-loss drugs and specialty ...

August 2, 2023, 7:37 am

Mgc pharmaceuticals proposes fundraising for australian investors

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said it is looking to raise up to A$2.7 million (£1.39 million) via a share purchase plan for...

August 1, 2023, 7:59 am

Revolutin medicines to acquire eqrx in deal that will add $1 billion in cash to its balance sheet to fund r&d

Revolution medicines Inc. RVMD, +2.10% said Tuesday it has reached a definitive agreement to acquire EQ...

August 1, 2023, 7:43 am

Mineralys therapeutics to announce second quarter 2023 financial results and host conference call on monday, august 7, 2023

RADNOR, Pa., July 31, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on deve...

July 31, 2023, 4:05 pm

Passage bio welcomes dolan sondhi, ph.d. to board of directors

PHILADELPHIA, July 31, 2023 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic me...

July 31, 2023, 11:00 am

$pfe: buying weekly dips in pfizer before next big move

Pfizer, Inc. is an US American pharmaceutical and biotechnology company. Founded in 1849 and headquartered in New York, USA, it is a part of S&P100 an...

July 30, 2023, 12:52 am

2 healthcare stocks that could make you richer

As a producer of medicines for animals, Zoetis benefits from increased spending on pets. Thanks to a st...

July 29, 2023, 9:30 am

Astrazeneca number show how it is 'not a one-trick pony' - analyst

AstraZeneca PLC's (LSE:AZN) underlying quarterly performance shows it is "far from a one-trick pony" and its share price premium over peers is entire...

July 28, 2023, 8:23 am

Takeda says it has 40 clinical-stage medicines in the pipeline

Christophe Weber, CEO of Takeda, says there are some setbacks in research and development, but most of those drugs should fuel the company's growth in...

July 28, 2023, 12:46 am

Wave life sciences second quarter 2023 financial results scheduled for august 3, 2023

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA ...

July 27, 2023, 12:30 pm

The u.s.' inflation reduction act risks hampering innovation, says roche ceo

Roche CEO Thomas Schinecker warns that sections of the U.S. Inflation Reduction Act could stifle the development of new medicines....

July 27, 2023, 8:11 am

Roche: have abandoned some trials due to u.s. drug pricing plans

Roche said it had abandoned certain drug development projects or acquisitions under consideration because of planned price cuts in best-selling prescr...

July 27, 2023, 2:24 am

Monte rosa therapeutics appoints dr. anthony m. manning to board of directors

BOSTON, July 26, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel molec...

July 26, 2023, 11:30 am

Benitec biopharma announces 1-for-17 reverse stock split effective july 26, 2023

HAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene the...

July 25, 2023, 5:00 pm

Aquestive therapeutics to report second quarter 2023 financial results and recent business highlights on august 7 and host conference call on august 8 at 8:00 a.m. et

WARREN, N.J., July 25, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the “Company” or “Aquestive”), a pharmaceutical ...

July 25, 2023, 4:01 pm

Annexon to report archer phase 2 trial results in geographic atrophy at asrs 2023

Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ET BRISBANE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — ...

July 24, 2023, 10:30 am

Gsk's hiv prevention drug gets european marketing nod

GSK Plc said on Monday that its HIV-focused unit ViiV Healthcare's cabotegravir injected drug and tablets got marketing authorisation from the Europea...

July 24, 2023, 2:22 am

Should income investors buy this blue chip stock?

Novartis' exceptional lineup of medicines produced stellar results in Q2. The company's market-beating ...

July 23, 2023, 8:30 am


Search within

Pages Search Results: